Henry Schein Elects Board of Directors at Annual Stockholder Meeting

Henry Schein, Inc. (NASDAQ: HSIC), the largest distributor of healthcare products and services to office-based practitioners in the combined North American and European markets, announced the election of 13 directors, including one new director, at the Company’s annual stockholder meeting today in Melville, N.Y. Karyn Mashima, Senior Vice President, Strategy and Technology for Avaya, a leading global provider of business communications applications, systems and services, joins the 12 current directors of the Henry Schein Board who were reelected today. In addition to Ms. Mashima, Henry Schein stockholders reelected 12 directors to the Board, including: Barry J. Alperin, Retired Vice Chairman, Hasbro, Inc., and a director since 1996; Gerald A. Benjamin, Henry Schein Executive Vice President and Chief Administrative Officer, and a director since 1994; Stanley M. Bergman, Henry Schein Chairman and Chief Executive Officer, and a director since 1982; James P. Breslawski, Henry Schein President and Chief Operating Officer, and a director since 1992; Paul Brons, Former Member, Board of Management, Akzo Nobel, N.V., and a director since 2005; Margaret A. Hamburg, M.D., Former Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services, Former Commissioner of Health for the City of New York, and a director since 2003; Donald J. Kabat, Retired Partner, Accenture, Ltd., and a director since 1996; Philip A. Laskawy, Retired Chairman, Ernst & Young, LLP, and a director since 2002; Norman S. Matthews, Former President, Federated Department Stores, Inc., and a director since 2002; Mark E. Mlotek, Henry Schein Executive Vice President, Corporate Business Development, and a director since 1995; Steven Paladino, Henry Schein Executive Vice President and Chief Financial Officer, and a director since 1992; and Louis W. Sullivan, M.D., Former U.S. Secretary of Health and Human Services, Founding Dean, Director and President Emeritus of the Morehouse School of Medicine, and a director since 2003. About Karyn Mashima With more than 25 years of experience in guiding technology product teams, Ms. Mashima currently serves as Senior Vice President Strategy and Technology of Avaya, with responsibility for Avaya Labs Research, and Chief Technology Officer (technology strategy and architecture), with responsibility for business planning and market intelligence. "As a Company committed to remaining a technology leader in our industry, we are delighted to welcome Karyn to the Henry Schein Board of Directors,” said Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein. "Karyn brings to our Board her experience with some of the largest, most well respected companies in the world. Her keen grasp of customer needs, technological possibilities, and her ability to identify the rate at which customers are able to absorb new technology have earned Karyn a well-deserved reputation as a visionary in her industry. Our Board looks forward to the valuable contributions that Karyn will make to our Company as we expand the range of technology-driven products and services that we provide to our customers.” Prior to her current position, Ms. Mashima held a similar post with the Enterprise Networks unit of Lucent Technologies. She joined AT&T in 1994 to lead the Advanced Multimedia Communications Systems Group. Previously, Ms. Mashima was at Hewlett-Packard, where she championed HP Overview. She began her career at Xerox as a pioneer on Internet Protocol Technology and the Star Workstation. Ms. Mashima frequently is asked to address industry groups. In 2007, she led a workshop session on Innovation at the World Economic Forum (WEF) in Dallian, China; another WEF workshop session on Early Warning and Crisis Preparedness in Davos, Switzerland; and was the keynote speaker at ComputerWorld’s CIO conference with a focus on Next Generation Communication Systems. Ms. Mashima also has addressed Forrester’s GigaWorld Conference in Prague, IDC’s IP Telephony Conference in Copenhagen, Interop Moscow and Interop Atlanta. "I am delighted to join a Board that already includes so many distinguished directors,” said Ms. Mashima. "Before accepting this appointment, I had the opportunity to meet extensively with the senior leadership of Henry Schein and was impressed by the Company’s commitment to technology, to the highest standards of corporate conduct, and by the Team Schein culture that drives the organization. I am eager to contribute a new perspective on strategic technology and business issues that will enable Henry Schein to continue its remarkable growth for many years to come.” About Henry Schein Henry Schein, a Fortune 500® company and a member of the Nasdaq 100® Index, is recognized for its excellent customer service and highly competitive prices. The Company's four business groups – Dental, Medical, International and Technology – serve more than 550,000 customers worldwide, including dental practitioners and laboratories, physician practices and animal health clinics, as well as government and other institutions. The Company operates through a centralized and automated distribution network, which provides customers in more than 200 countries with a comprehensive selection of more than 90,000 national and Henry Schein private-brand products in stock, as well as more than 100,000 additional products available as special-order items. Henry Schein also offers a wide range of innovative value-added practice solutions for healthcare professionals, such as ArubA®, the Company’s electronic catalog and ordering system. Its leading practice-management software solutions have a user base of more than 52,000 practices, including DENTRIX®, Easy Dental®, Oasis® and EXACT® for dental practices, MicroMD® for physician practices, and AVImark® for animal health clinics. Headquartered in Melville, N.Y., Henry Schein employs over 12,000 people and has operations or affiliates in 20 countries. The Company's net sales reached a record $5.9 billion in 2007. For more information, visit the Henry Schein Web site at www.henryschein.com.